Short answer
Alnylam Pharmaceuticals (ALNY) filed an 8-K current report with the SEC on April 30, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). April 30, 2026 filing references a press release covering Alnylam’s reported results.
Alnylam Pharmaceuticals 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- April 30, 2026 filing references a press release covering Alnylam’s reported results
- Detailed financial results and management commentary are contained in Exhibit 99.1
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Alnylam Pharmaceuticals 8-K filings
Get the next ALNY 8-K as it lands
Follow ALNY for push alerts, or ask the research agent what this filing means.